[Session 5] JAGntd-GHIT NTD webinar series: Challenges of expanding access to health products in the fight against NTDs
Neglected tropical diseases (NTDs) prevail among the hard-to-reach populations in the world. To protect them from NTDs, developing good health products is necessary, but is not sufficient without creating access to them. Access is a complex matter: no single organization can create it successfully. This webinar series will clarify some conceptual aspects about access, discuss key access challenges from different perspectives and how these can be overcome. The webinar series also considers how Japanese actors might be able to contribute to addressing some of those access challenges.
[Language] English. Simultaneous translation into Japanese will be provided.
[Organizer] Japan Alliance on Global Neglected Tropical Diseases (JAGntd)
[Sponsor] GHIT Fund
Session 5: Nudging the Industry (1): Visualizing Pharmaceutical Companies' Efforts
Session 5 introduces the work done by the Access to Medicine Foundation (AMF). AMF is an independent non-profit organization whose mission is to stimulate and guide pharmaceutical companies to improve access to medicine in low- and middle-income countries. By publishing the Access to Medicine Index, the AMF fosters competition to improve access among pharma companies. The invited speaker will explain what AMF considers as key access barriers and how AMF has changed the pharma industry towards better access. This session also explores a view of a Japanese investment company that endorses AMF. The audience will understand the implication of AMF’s work on access to NTD medicines in the world.
[Date/Time] Thursday, January 20, 2022 17: 00-18: 00 (Japan time)
・Margo Warren; Access to Medicine Foundation
・Shinichi Kohguchi; Sumitomo Mitsui Trust Asset Management Co., Ltd.
・Session 6: "Nudging the Industry (2): Patent as a Barrier or Leverage?" February 2022
・Session 7: "Financing: Who Pays for What?" March 2022
Replay past webinars on the JAGntd Youtube channel.
Session 1: "Concepts and definitions: What is access?"
Session 2: "Developer’s perspective: Fexinidazole for African Trypanosomiasis"
Session 3: "Country's Perspective: Introduction of Pediatric Praziquantel for Schistosomiasis in Tanzania"
Session 4: "WHO/ESPEN’s perspective: Strengthening national NTD programs in Africa"